MYC and cancer: Thus, we next investigated whether ROS reduction by apigenin could lead to STAT3 de-phosphorylation and whether STAT3 inhibition could down-regulate the expression of downstream molecules such as c-myc and cyclin D1 that sustain cancer cell proliferation and/or affect cellular or viral anti-apoptotic molecules.